Linnaeus Bio Sciences

Linnaeus Bioscience Inc is dedicated to the discovery, development and commercialization of innovative technologies that accelerate drug discovery. Our Bacterial Cytological Profiling (BCP) platform provides a revolutionary new approach for discovering new compounds to treat microbial disease and emerging drug resistant bacterial infections. 

Focus area
Infectious Diseases & Vaccines
Commencement date
10/02/2012